Related Experiment Video

Updated: Jul 20, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

Pharmacotherapy of child and adolescent depression

Carmen Moreno1, Ansley M Roche, Laurence L Greenhill

  • 1Division of Child Psychiatry, New York State Psychiatric Institute, College of Physicians and Surgeons of Columbia University, 1051 Riverside Drive, Unit 74, New York, NY 10032, USA. mdm2109@columbia.edu

Child and Adolescent Psychiatric Clinics of North America
|September 6, 2006
PubMed

Insights

Pediatric depression is a serious condition often missed in youth. This review examines antidepressant efficacy and safety, crucial for guiding treatment decisions in children and adolescents.

Area of Science:

  • Child and Adolescent Psychiatry
  • Pharmacology
  • Mental Health Research

Background:

  • Pediatric depression is common, recurrent, and leads to significant impairment.
  • Despite increased research, pediatric depression is underdiagnosed and undertreated.
  • Antidepressant use in youth carries potential risks, including suicidal ideation.

Purpose of the Study:

  • To review the efficacy and safety of antidepressants for pediatric depression.
  • To provide clinicians with evidence-based guidance for treatment recommendations.
  • To address the complexities of antidepressant use in children and adolescents.

Main Methods:

  • Systematic review of existing data on antidepressant trials in pediatric depression.
  • Analysis of efficacy and safety profiles of various antidepressant classes.
  • Evaluation of regulatory warnings and their implications.

Main Results:

  • Few antidepressant trials show positive results in pediatric depression.
  • Concerns exist regarding selective serotonin reuptake inhibitors and newer antidepressants.
  • Potential link between antidepressant use and increased suicidal ideation or attempts in youth.

Conclusions:

  • Careful consideration of antidepressant risks and benefits is essential for pediatric depression treatment.
  • Further research is needed to optimize antidepressant therapy for young patients.
  • Clinicians require updated data to make informed treatment decisions for depressed children and adolescents.

More Related Videos

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...